BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35231859)

  • 1. The involvement of the MAPK pathway in pilocytic astrocytomas.
    Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
    Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
    Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.
    Raabe EH; Lim KS; Kim JM; Meeker A; Mao XG; Nikkhah G; Maciaczyk J; Kahlert U; Jain D; Bar E; Cohen KJ; Eberhart CG
    Clin Cancer Res; 2011 Jun; 17(11):3590-9. PubMed ID: 21636552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
    Tomić TT; Olausson J; Wilzén A; Sabel M; Truvé K; Sjögren H; Dósa S; Tisell M; Lannering B; Enlund F; Martinsson T; Åman P; Abel F
    PLoS One; 2017; 12(4):e0175638. PubMed ID: 28448514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of disseminated pilocytic astrocytomas.
    Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics.
    Salles D; Laviola G; Malinverni ACM; Stávale JN
    J Child Neurol; 2020 Oct; 35(12):852-858. PubMed ID: 32691644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.
    Reis GF; Bloomer MM; Perry A; Phillips JJ; Grenert JP; Karnezis AN; Tihan T
    Mod Pathol; 2013 Oct; 26(10):1279-87. PubMed ID: 23702730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel GIT2-BRAF fusion in pilocytic astrocytoma.
    Helgager J; Lidov HG; Mahadevan NR; Kieran MW; Ligon KL; Alexandrescu S
    Diagn Pathol; 2017 Nov; 12(1):82. PubMed ID: 29141672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilocytic astrocytoma in adults: Histopathological, immunohistochemical and molecular study with clinical association.
    Salles D; Santino SF; Diana P; Malinverni ACM; Stávale JN
    Pathol Res Pract; 2023 Dec; 252():154942. PubMed ID: 37984046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
    Jeuken JW; Wesseling P
    J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilomyxoid astrocytomas: a short review.
    Kulac I; Tihan T
    Brain Tumor Pathol; 2019 Apr; 36(2):52-55. PubMed ID: 30945015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.
    Forshew T; Tatevossian RG; Lawson AR; Ma J; Neale G; Ogunkolade BW; Jones TA; Aarum J; Dalton J; Bailey S; Chaplin T; Carter RL; Gajjar A; Broniscer A; Young BD; Ellison DW; Sheer D
    J Pathol; 2009 Jun; 218(2):172-81. PubMed ID: 19373855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
    Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
    Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
    Tatevossian RG; Lawson AR; Forshew T; Hindley GF; Ellison DW; Sheer D
    J Cell Physiol; 2010 Mar; 222(3):509-14. PubMed ID: 19937730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
    Sadighi Z; Slopis J
    J Child Neurol; 2013 May; 28(5):625-32. PubMed ID: 23439714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
    Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.
    Bar EE; Lin A; Tihan T; Burger PC; Eberhart CG
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):878-87. PubMed ID: 18716556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
    Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.